Skip to main content
. Author manuscript; available in PMC: 2016 Mar 3.
Published in final edited form as: Anticancer Res. 2015 Jul;35(7):3969–3977.

Table III.

Distribution of candidate miRNA expression by real time PCR in cases and controls from the New York site of the BCFR in the validation phase.

ΔCt (Mean, SD) Cases (n=28) Controls (n=28) Fold Change
has-miR-144-3p 12.7 (1.5) 12.3 (1.0) 0.78
has-miR-451a 6.3 (1.8) 5.9 (1.2) 0.78
has-miR-144-5p 13.3 (1.3) 13.1 (1.0) 0.86
has-miR-183-5P 13.9 (1.3) 13.6 (1.0) 0.81
hsa-miR-708-5p 11.9 (2.2) 12.2 (2.2) 1.3

Fold change=2^(–ΔΔCt).